RTS,S/AS01 malaria vaccine and child mortality

Affiliations

¹ Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau. Electronic address: p.aaby@bandim.org.
² Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau; Research Centre for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, 2300 Copenhagen, Denmark.
³ Department of Paediatrics, Kolding Hospital, Kolding, Denmark.
⁴ Research Centre for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, 2300 Copenhagen, Denmark.

Comment

Peter Aaby et al. Lancet. 2015.

. 2015 Oct 31;386(10005):1735-6.

doi: 10.1016/S0140-6736(15)00693-5.

¹ Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau. Electronic address: p.aaby@bandim.org.
² Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau; Research Centre for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, 2300 Copenhagen, Denmark.
³ Department of Paediatrics, Kolding Hospital, Kolding, Denmark.
⁴ Research Centre for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, 2300 Copenhagen, Denmark.

No abstract available

Comment on

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.
RTS,S Clinical Trials Partnership. RTS,S Clinical Trials Partnership. Lancet. 2015 Jul 4;386(9988):31-45. doi: 10.1016/S0140-6736(15)60721-8. Epub 2015 Apr 23. Lancet. 2015. PMID: 25913272 Free PMC article. Clinical Trial.